Clinical performance of the Osia™ system, a new active osseointegrated implant system. Results from a prospective clinical investigation

Simple item page
dc.coverageDOI: 10.1080/00016489.2019.1691744
dc.creatorGoycoolea, Marcos
dc.creatorRibalta, Gloria
dc.creatorTocornal, Francisco
dc.creatorLevy, Raquel
dc.creatorAlarcón, Pilar
dc.creatorBryman, Martin
dc.creatorCagnacci, Byanka
dc.creatorCatenacci, Catherine
dc.creatorOyanguren, Valeria
dc.creatorVilches, Ignacia
dc.creatorBriones, Verónica
dc.creatorGarcía, Raimundo
dc.date2020
dc.date.accessioned05-01-2026 18:04
dc.date.available05-01-2026 18:04
dc.description<p>Background: Bone-conduction hearing implants are standard of care devices. Aims/Objectives: Evaluation of a new active magnetic bone-conduction hearing implant: Cochlear Osia™ system. Material and methods: This device uses a transcutaneous connection between an external sound-processor and an osseointegrated implant that generates vibrations using a piezoelectricity-based internal bone-conduction system. Nine patients with conductive-hearing loss were implanted. Surgical efficacy, hearing performance and quality-of-life were evaluated. Hearing performance in quiet and in noise was compared with unaided hearing and hearing with the Baha 5 Power<sup>®</sup> Sound Processor on a softband. Results: Surgery and healing were uneventful. Statistically significant improvements in audibility, speech-understanding, speech-recognition and quality-of-sound in noise and quiet were found for the Osia™ compared to preoperative unaided hearing and aided hearing with the Baha 5 Power<sup>®</sup> Sound Processor on a softband. The active vibration system provided improvement at low and high frequencies. At 6 months postoperatively, all patients continue to use the device. Conclusions and significance: The Osia™ is safe and effective, improving speech-recognition in quiet and in noise, at low and high frequencies, thus delivering better quality-of-hearing than passive devices.</p>eng
dc.descriptionBackground: Bone-conduction hearing implants are standard of care devices. Aims/Objectives: Evaluation of a new active magnetic bone-conduction hearing implant: Cochlear Osia™ system. Material and methods: This device uses a transcutaneous connection between an external sound-processor and an osseointegrated implant that generates vibrations using a piezoelectricity-based internal bone-conduction system. Nine patients with conductive-hearing loss were implanted. Surgical efficacy, hearing performance and quality-of-life were evaluated. Hearing performance in quiet and in noise was compared with unaided hearing and hearing with the Baha 5 Power® Sound Processor on a softband. Results: Surgery and healing were uneventful. Statistically significant improvements in audibility, speech-understanding, speech-recognition and quality-of-sound in noise and quiet were found for the Osia™ compared to preoperative unaided hearing and aided hearing with the Baha 5 Power® Sound Processor on a softband. The active vibration system provided improvement at low and high frequencies. At 6 months postoperatively, all patients continue to use the device. Conclusions and significance: The Osia™ is safe and effective, improving speech-recognition in quiet and in noise, at low and high frequencies, thus delivering better quality-of-hearing than passive devices. © 2020, © 2020 Acta Oto-Laryngologica AB (Ltd).spa
dc.identifierhttps://investigadores.uandes.cl/en/publications/d68d6c27-8890-4d44-a044-ebdc94f6c664
dc.languageeng
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.sourcevol.140 (2020) date: 2020-03-03 nr.3 p.212-219
dc.subjectActive bone-conduction hearing-implant
dc.subjectBaha
dc.subjectBone anchored hearing aid
dc.subjecthearing improvement in high frequencies
dc.subjectquality-of-hearing
dc.titleClinical performance of the Osia™ system, a new active osseointegrated implant system. Results from a prospective clinical investigationeng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
Pure-CRIS